Clinical Trial Update: Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for desmopressin oral disintegrating tablets targeting nocturia due to nocturnal polyuria in Japanese male subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• Desmopressin ODT (desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Phase 3 | Status: COMPLETED